SCHEMBL19203662

SCHEMBL19203662

CC(=O)CCCCCN1C(=O)C(C)CC1O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PAOX Q6QHF9 3/20 0.41
GBA1 P04062 2/20 0.33
RXFP1 Q9HBX9 2/20 0.32
MAPK1 P28482 1/20 0.32
TSHR P16473 3/20 0.32
USP2 O75604 1/20 0.32
TNF P01375 1/20 0.32
LMNA P02545 1/20 0.32
CYP1A2 P05177 1/20 0.32
NFKB1 P19838 1/20 0.32
ACHE P22303 1/20 0.32
PDE4A P27815 1/20 0.32
ADORA2B P29275 1/20 0.32
PMP22 Q01453 1/20 0.32
PDE4B Q07343 1/20 0.32
PDE4C Q08493 1/20 0.32
PDE4D Q08499 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
BRD4 O60885 1/20 0.31
ALDH1A1 P00352 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22688335 0.94 PAOX (0.33) PAOXACHEALDH1A1
SCHEMBL20375297 0.87 TLR4 (0.32) ALDH1A1
SCHEMBL27316261 0.82 ALDH1A1 (0.34) GBA1MAPK1TSHRSMN1; SMN2ALDH1A1
SCHEMBL27309028 0.82 ALDH1A1 (0.34) GBA1MAPK1TSHRSMN1; SMN2ALDH1A1
SCHEMBL27320149 0.77 MTNR1A (0.34) MAPK1TSHRALDH1A1
SCHEMBL19203502 0.75 KDM4E (0.30) MAPK1
SCHEMBL20763500 0.75 EPHX2 (0.35) MAPK1TSHRLMNASMN1; SMN2ALDH1A1
SCHEMBL19981680 0.75 PAOX (0.34) PAOXACHE
SCHEMBL24686276 0.75 GAA (0.44) LMNACYP1A2SMN1; SMN2ALDH1A1GAA
SCHEMBL20051792 0.74 CAPN1 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023000131-A1 ANTIBODY DRUG CONJUGATE LOADED WITH DOUBLE TOXINS AND APPLICATION THEREOF 烟台迈百瑞国际生物医药股份有限公司 2023-01-26 WO disclosed
WO-2017132173-A1 MAYTANSINOID DERIVATIVES, CONJUGATES THEREOF, AND METHODS OF USE REGENERON PHARMACEUTICALS, INC. (US) 2017-08-03 WO disclosed